Arachidonylsulfonyl derivatives as cannabinoid CB1 receptor and fatty acid amide hydrolase inhibitors
- 14 August 2003
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (19) , 3301-3303
- https://doi.org/10.1016/s0960-894x(03)00721-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Cannabinoid CB1 Receptor Chemical Affinity Probes: Methods Suitable for Preparation of Isopropyl [11,12-3H]Dodecylfluorophosphonate and [11,12-3H]Dodecanesulfonyl FluorideSynthetic Communications, 2003
- Selective Inhibitors of Fatty Acid Amide Hydrolase Relative to Neuropathy Target Esterase and Acetylcholinesterase: Toxicological ImplicationsToxicology and Applied Pharmacology, 2002
- Polyunsaturated Nitroalkanes and Nitro-Substituted Fatty AcidsSynthesis, 2001
- Fatty Acid Amide Hydrolase Inhibition by Neurotoxic Organophosphorus PesticidesToxicology and Applied Pharmacology, 2001
- Synthesis and Biological Activities of 2-Arachidonoylglycerol, an Endogenous Cannabinoid Receptor Ligand, and Its Metabolically Stable Ether-linked Analogues.CHEMICAL & PHARMACEUTICAL BULLETIN, 2000
- Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestineBritish Journal of Pharmacology, 1998
- Evidence that methyl arachidonyl fluorophosphonate is an irreversible cannabinoid receptor antagonistBritish Journal of Pharmacology, 1997
- Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidaseBiochemical Pharmacology, 1997
- Fatty Acid Sulfonyl Fluorides Inhibit Anandamide Metabolism and Bind to the Cannabinoid ReceptorBiochemical and Biophysical Research Communications, 1997
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992